Dose‐dependent elevation in amylase and lipase in response to teduglutide administration

Teduglutide has been used for patients with short bowel syndrome. Teduglutide can be a dose‐dependent triggering factor to increased amylase and lipase. Serum amylase and lipase levels should be monitored routinely for patients on teduglutide, and they should be screened before the initiation of tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Joshua, Kim, Myoung, Kim, Dong Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509918/
https://www.ncbi.nlm.nih.gov/pubmed/31110724
http://dx.doi.org/10.1002/ccr3.2127
_version_ 1783417345069285376
author Lee, Joshua
Kim, Myoung
Kim, Dong Wook
author_facet Lee, Joshua
Kim, Myoung
Kim, Dong Wook
author_sort Lee, Joshua
collection PubMed
description Teduglutide has been used for patients with short bowel syndrome. Teduglutide can be a dose‐dependent triggering factor to increased amylase and lipase. Serum amylase and lipase levels should be monitored routinely for patients on teduglutide, and they should be screened before the initiation of treatment.
format Online
Article
Text
id pubmed-6509918
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65099182019-05-20 Dose‐dependent elevation in amylase and lipase in response to teduglutide administration Lee, Joshua Kim, Myoung Kim, Dong Wook Clin Case Rep Case Reports Teduglutide has been used for patients with short bowel syndrome. Teduglutide can be a dose‐dependent triggering factor to increased amylase and lipase. Serum amylase and lipase levels should be monitored routinely for patients on teduglutide, and they should be screened before the initiation of treatment. John Wiley and Sons Inc. 2019-04-05 /pmc/articles/PMC6509918/ /pubmed/31110724 http://dx.doi.org/10.1002/ccr3.2127 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Lee, Joshua
Kim, Myoung
Kim, Dong Wook
Dose‐dependent elevation in amylase and lipase in response to teduglutide administration
title Dose‐dependent elevation in amylase and lipase in response to teduglutide administration
title_full Dose‐dependent elevation in amylase and lipase in response to teduglutide administration
title_fullStr Dose‐dependent elevation in amylase and lipase in response to teduglutide administration
title_full_unstemmed Dose‐dependent elevation in amylase and lipase in response to teduglutide administration
title_short Dose‐dependent elevation in amylase and lipase in response to teduglutide administration
title_sort dose‐dependent elevation in amylase and lipase in response to teduglutide administration
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509918/
https://www.ncbi.nlm.nih.gov/pubmed/31110724
http://dx.doi.org/10.1002/ccr3.2127
work_keys_str_mv AT leejoshua dosedependentelevationinamylaseandlipaseinresponsetoteduglutideadministration
AT kimmyoung dosedependentelevationinamylaseandlipaseinresponsetoteduglutideadministration
AT kimdongwook dosedependentelevationinamylaseandlipaseinresponsetoteduglutideadministration

Ejemplares similares